Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Inventory Average (2022 - 2025)

Historic Inventory Average for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Q3 2025 value amounting to $19.4 million.

  • Arcutis Biotherapeutics' Inventory Average rose 3888.87% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year increase of 3888.87%. This contributed to the annual value of $13.8 million for FY2024, which is 3395.97% up from last year.
  • As of Q3 2025, Arcutis Biotherapeutics' Inventory Average stood at $19.4 million, which was up 3888.87% from $16.5 million recorded in Q2 2025.
  • Over the past 5 years, Arcutis Biotherapeutics' Inventory Average peaked at $19.4 million during Q3 2025, and registered a low of $5.9 million during Q4 2022.
  • In the last 4 years, Arcutis Biotherapeutics' Inventory Average had a median value of $13.5 million in 2023 and averaged $13.0 million.
  • In the last 5 years, Arcutis Biotherapeutics' Inventory Average surged by 12880.47% in 2023 and then surged by 552.37% in 2024.
  • Quarter analysis of 4 years shows Arcutis Biotherapeutics' Inventory Average stood at $5.9 million in 2022, then surged by 128.8% to $13.5 million in 2023, then grew by 5.52% to $14.3 million in 2024, then soared by 35.75% to $19.4 million in 2025.
  • Its Inventory Average was $19.4 million in Q3 2025, compared to $16.5 million in Q2 2025 and $15.6 million in Q1 2025.